Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caphosol for Prevention of Oral Mucositis in Children and Young Adults
NCT02539342Phase 3Terminated
- Sponsor
- Medical College of Wisconsin
- Start
- Oct 2016
- Primary completion
- Mar 2017
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of supersaturated calcium phosphate rinse in oral mucositis (OM) (2 arms), sponsored by Medical College of Wisconsin. Primary endpoint: Development of Oral Mucositis (Grade >/= 2) at 24 months. Started Oct 2016; status: terminated.
02
Drugs
supersaturated calcium phosphate rinse
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT02539342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02539342.